Andreas Terpin

Chief Executive Officer at Xenios AG

57 year

Health Technology

Profile

Andreas Terpin is associated with Xenios AG as the Chief Executive Officer.
He is also associated with novalung GmbH as the Co-Managing Director since 2018.

Andreas Terpin active positions

Companies	Position	Start
Xenios AG Xenios AG Medical SpecialtiesHealth Technology Xenios AG develops and manufactures innovative devices for minimally invasive lung and heart support. Its novalung iLA, i–cor, and medos devices provide pulmonary and cardiac assist for a broad range of support levels on the unique XENIOS platform. The company is headquartered in Heilbronn, Germany.	Chief Executive Officer	-

All active positions of Andreas Terpin

Former positions of Andreas Terpin

Companies	Position	End
novalung GmbH novalung GmbH Medical SpecialtiesHealth Technology novalung GmbH engages in the development and marketing of solutions for the treatment of acute and chronic lung failure. The firm specializes in the design of protective and mechanical ventilation devices, membrane ventilators, cannulas, heaters and coolers, as well as monitoring and support systems. It offers a lung failure therapy platform, which performs any level of carbon dioxide removal and oxygenation in acute respiratory failure. The company was founded by Georg Matheis in February 2003 and is headquartered in Heilbronn, Germany.	Chief Executive Officer	-

See the detail of Andreas Terpin's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andreas Terpin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Xenios AG Xenios AG Medical SpecialtiesHealth Technology Xenios AG develops and manufactures innovative devices for minimally invasive lung and heart support. Its novalung iLA, i–cor, and medos devices provide pulmonary and cardiac assist for a broad range of support levels on the unique XENIOS platform. The company is headquartered in Heilbronn, Germany.	Health Technology
novalung GmbH novalung GmbH Medical SpecialtiesHealth Technology novalung GmbH engages in the development and marketing of solutions for the treatment of acute and chronic lung failure. The firm specializes in the design of protective and mechanical ventilation devices, membrane ventilators, cannulas, heaters and coolers, as well as monitoring and support systems. It offers a lung failure therapy platform, which performs any level of carbon dioxide removal and oxygenation in acute respiratory failure. The company was founded by Georg Matheis in February 2003 and is headquartered in Heilbronn, Germany.	Health Technology